Serum homocysteine, vitamin B 12 and folic acid levels in different types of glaucoma

BMC Ophthalmology

Volumn 6, Issue , 2006, Pages

  Cumurcu, Tongabay ^a   Sahin, Semsettin ^a   Aydin, Erdinc ^a  

^a GAZIOSMANPASA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; AGED; ARTICLE; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENZYME IMMUNOASSAY; FEMALE; FOLIC ACID BLOOD LEVEL; GLAUCOMA; HUMAN; IMMUNOASSAY; MALE; MEASUREMENT; PATIENT; PROSPECTIVE STUDY; VITAMIN BLOOD LEVEL; ANALYSIS OF VARIANCE; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; MIDDLE AGED; OPEN ANGLE GLAUCOMA; OSMOLARITY; PSEUDOEXFOLIATION;

AGED; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; EXFOLIATION SYNDROME; FEMALE; FOLIC ACID; GLAUCOMA; GLAUCOMA, OPEN-ANGLE; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; VITAMIN B 12;

EID: 33644995244     PISSN: 14712415     EISSN: 14712415     Source Type: Journal    
DOI: 10.1186/1471-2415-6-6     Document Type: Article

References (31)

1. Flammer J, Orgul S, Costa VP, Orzalesi N, Krieglstein GK, Serra LM, Renard JP, Stefansson E: The impact of ocular blood flow in glaucoma. Prog Retin Eye Res 2002, 21:359-393.
2. Hayreh SS: Blod flow in the optic nevre head and factors that may influence it. Prog Retin Eye Res 2001, 20:595-624.
3. Bousse V, Newman NJ, Sternberg P: Retinal vein occlusion and transient monocular visual loss associated with hiperhomocysteinemia. Am J Ophthalmol 1997, 124:257-260.
4. Cahill M, Karabatzaki M, Meleady R, Refsum H, Ueland P, Shields D, Money D, Graham I: Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease. Br J Ophthalmol 2000, 84:154-157.
5. Pianka P, Almog Y, Man O, Goldstein M, Sela BA, Lowenstein A: Hyperhomocysteinemia in patients with nonarteritic anterior iscemic optic neuropathy, central retinal artery occlusion, and central retinal vein occlusion. Ophthalmology 2000, 107:1588-1592.
6. Lowenstein A, Goldstein M, Winder A, Lazar M, Eldor A: Retinal vein occlusion associated with methylenetetrahydrofolate reductase mutation. Ophthalmology 1999, 106:1817-1820.
7. Brown BA, Marx JL, Ward TP, Hollifield RD, Dick JS, Brozetti JJ, Howard RS, Thach AB: Homocysteine: a risk factor for retinal venous occlusive disease. Ophthalmology 2002, 109:287-290.
8. Finkelstein JD: The matabolism of homocysteine: pathways and regulation. Eur J Pediatr 1998, 157:40-44.
9. Ueland PM, Refsum H, Brattstrom L: Plasma homocysteine and cardiovascular disease. Atherosclerotic cardiovascular disease, hemostasis, and endothelial function. Marcel Dekker, New York; 1992:183-236.
10. Stampfer MJ, Malinow MR, Willet WJ, Newcomer LM, Upson B, Ullman D, Tishler PV, Hennekens CH: A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. JAMA 1992, 268:877-881.
11. Perry IJ, Refsum H, Moris RW, Ebrahim SB, Ueland PM, Shaper AG: Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995, 346:1395-1398.
12. Warsi AA, Davies B, Morris-Stiff G, Hullin D, Lewis MH: Abdominal aortic aneurysm and its correlation to plasma homocysteine, and vitamins. Eur J Vasc Endovasc Surg 2004, 27:75-79.
13. Leblhuber F, Walli J, Artner-Dworzak E, Vrecko K, Widner B, Reibnegger G, Fuchs D: Hyperhomocysteinemia in dementia. J Glaucoma 2003, 107:1469-1474.
14. Bleich S, Jünemann A, Von Ahsen N, Schöltzer-Scherland U, Beck G, Naumann GOH, Kornhuber J: Homocysteine and risk of open angelglaucoma. J Neural Transm 2002, 109:1499-1504.
15. Leibovitch I, Kurtz S, Shemes G, Goldstein M, Sela BA, Lazar M, Lowenstein A: Hyperhomocysteinemia in pseudoexfoliative glaucoma. J Glaucoma 2003, 12:36-39.
16. Vessani RM, Ritch R, Liebmann JM, Jofe M: Plasma homocysteine is elevated in patients with exfoliative syndrome. Am J Ophthalmol 2003, 136:41-46.
17. Puustjarvi T, blomster H, Kontkanen M, Punnonen K, Terasvirta M: Plasma and aqueous humour levels of homocysteine in exfoliation syndrome. Graefes Arch Clin Exp Ophthalmol 2004, 242:749-54.
18. Altintas O, Maral H, Yuksel N, Karabas VL, Dillioglugil MO, Caglar Y: Homocysteine and nitric oxide levels in plasma of patients with pseudoexfoliation syndrome, pseudoexfoliation glaucoma, and primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol 2005, 243(7):677-83.
19. Wang G, Medeiros FA, Barshop BA, Weinreb RN: Total plasma homocysteine and primary open-angle glaucoma. Am J Ophthalmol 2004, 137:401-6.
20. Brunelli T, Prisco D, Fedi S, Rogolino A, Farsi A, Marcucci R, Giusti B, Pratesi C, Pulli R, Gensini GF, Abbate R, Gensini GF: High prevelance of mild hyperhomocysteinemia in patients with abdominal aortic aneurysm. J Vasc Surg 2000, 32:531-536.
21. Hankey GJ, Eikelbom JW: Homocysteine and stroke. Curr opin Neurol 2001, 14:95-102.
22. Hankey GJ, Eikelboom JW: Homocysteine and vascular disease. Lancet 1999, 357:407-413.
23. Bagi Z, Unguari Z, Koller A: Xantine oxidase-derived reactive oxygen species convert flour-induced arteriolar dilatation to constriction in hyperhomocysteinemia. Arterioscler Thromb Vasc Biol 2002, 22:28-33.
24. Koliakos GG, Konstas AG, Schlötzer-Schrehardt U, Hollo G, Mitova D, Kovatchev D, Maloutas S, Georgiadis N: Endothelin-1 concentration is increased in aqueous humour of patients with exfoliation syndrome. Br J Ophthalmol 2004, 88:523-527.
25. Sela BA: ADMA (asymmetric dimethylarginine) the inhibitor of nitric oxide (NO) synthesis: a new marker for vascular pathology. Harefuah 2005, 144:655-9.
26. Asano N, Schöltzer-Schrehardt U, Nauman GO: A hystopathologic study of iris changes in pseudoexfoliation syndrome. Ophthalmology 1995, 102:1279-90.
27. Karjalainen K, Tarkkanen A, Merenmies L: Exfoliation syndrome in enucleated haemorrhagic and absolute glaucoma. Acta Ophthalmol 1987, 65:320-322.
28. Cursiefen C, Hammer T, Küchle M, Naumann GO, Schlötzer- Screhardt U: Pseudoexfoliation syndrome in eyes with ischemic central retinal vein occlusion. A histopathologic and electron microscopic study. Acta Ophthalmol Scand 2001, 79:476-478.
29. Mitchell p, Wang JJ, Smith W: Association of pseudoexfoliation with increased vascular risk. Am J Ophthalmol 1997, 124:685-687.
30. Schumacher S, Schlötzer-Screhardt U, Martus P, Lang W, Naumann GO: Pseudoexfoliation syndrome and aneurysms of the abdominal aorta. Lancet 2001, 357:359-360.
31. Repo LP, Suhonen MT, Terasvitra ME, Koivisto JK: Color Doppler imaging of the ophthalmic artery blood flow spectra of patients who have had a transient ischemic attack. Correlations with generalized iris transluminance and pseudoexfoliation syndrome. Ophthalmology 1995, 102:1199-1205.